




The marine environment is known to be rich sources of 
biologically active compounds due to their tremendous biodiversity.  A 
quantitative analysis of marine organisms demonstrated that more 
than 20,000 compounds have been isolated from marine 
microorganisms, micro/macro algae and invertebrates.  Among 
marine seaweeds, the members of Phaeophyceae (marine brown algae) 
have been one of the richest and most promising sources of bioactive 
primary and secondary metabolites, with a broad range of 
physiological and biochemical characteristics.  Several species of 
macro algae growing abundantly in the shallow waters of Gulf of 
Mannar Marine Biosphere Reserve (GoMBR; 80 49’–90 15’ N latitude 
and 780 11’–790 30’ E Longitude), which is one of the world’s richest 
regions from marine bio diversity perspective and the first marine 
Biosphere Reserve in South east Asia. 
In the present thesis abundantly available fifteen species of 
seaweeds were collected and washed thoroughly with fresh water and 
cleaned carefully to remove the extraneous matter.  They were shade 
dried, powdered and extracted with a mixture of dichloro methane and 
methanol (1:1 ratio). All the crude extracts were evaluated against 
gram positive and negative bacteria, brine shrimp, and anti-
proliferative activities on different cell lines.  Based on the preliminary 
investigations, it was found that the brown seaweed, Stoechospermum 
marginatum, exhibited multiple biological activities.  These 
observations have given me a clue that the secondary metabolites that 
are produced by S. marginatum, may have a beneficial molecule/s, 
which may possess potent anti-cancerous/anti-proliferative 
properties. Keeping in view, an extensive study was conducted on the 
vii 
 
brown seaweed, S. marginatum for isolation of bioactive substances.  
Bioassay directed fractionation and purification led to the successful 
isolation of ten bioactive spatane diterpinoids from a brown seaweed, 
S. marginatum.  These structures were determined by analyzing 1H, 
13C NMR and FAB-MS.   
The anti-proliferative/cytotoxic activities of these isolated 
compounds were investigated in different cancer cell lines and found 
that one of the spatane diterpinoids, 5 (R), 19 - diacetoxy -15,18 (R 
and S), dihydro spata-13, 16 (E)- diene (DDSD) has exhibited most 
significant cytotoxic properties against all the cell lines, i.e., Histiocytic 
lymphoma (U937), Acute monocytic leukemia (THP-1), Colon 
adenocarcinoma (COLO205), Promyelocytic leukemia (HL60), Human 
lung carcinoma (A549), Human breast cancer (MCF7) and mouse 
melanocarcinoma (B16F10) with IC50 values of 5.6, 14.21, 36.15, 
40.96, 26.35, 32.34 and 3.45 µg/mL, respectively.  It is evident from 
the results that the mouse melanocarcinoma (B16F10) cells were 
relatively more sensitive to the isolated compound, DDSD. 
Interestingly, the DDSD has exhibited fewer symptoms on the human 
peripheral blood mononuclear cells (PBMC) and mouse fibroblast cell 
lines (BALB/3T3 and NIH/3T3) with IC50 values of 90.18, 69.08 and 
59.80 µg/mL, respectively.  This data indicated that DDSD may 
selectively inhibit the viability of mouse melanoma cells, which is a 
highly desirable property of potential anticancer agents.  Light and 
florescence microscopy studies provide direct evidence that, the 
compound DDSD exhibited apoptotic activity on several cancerous cell 
lines.    
        The molecular mechanism of DDSD mediated apoptosis was also 
investigated for the first time in in vitro and in vivo B16F10 melanoma 
mouse models. Induction of apoptosis in B16F10 cells was 
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characterized by colony forming inhibition, wound healing inhibition, 
cell membrane blebbing, chromatin condensation, DNA fragmentation, 
which leads to cell growth inhibition in a concentration-dependent 
manner. Data indicate that DDSD induced the generation of ROS, 
consequentially caused alteration in Bax/Bcl-2 ratio that disrupted 
the inner mitochondrial transmembrane potential (∆Ψm) resulting in 
cytochrome c redistribution to the cytoplasm and activation of 
caspase-mediated apoptotic pathway.  Flow cytometric analysis clearly 
indicated that the DDSD inducing phosphatidylserine externalization 
and mediated “S-phase” arrest in cell cycle.  In addition, results also 
found that DDSD induced apoptosis through deregulating PI3K/AKT 
signalling pathway.  The anti-tumor activity of DDSD was evaluated in 
C57BL/6 mice bearing B16F10 melanoma.  It effectively inhibited 
tumor growth (volume and weight) in a dose dependent manner, yet 
without apparent toxic effects.  Morphology and apoptotic status of 
tumor tissues in the treated mice were assessed by microscopy and 
TUNEL assay, respectively. 
        It was concluded from the experimental data that Spatane 
diterpinoid (DDSD) compound exhibits potent anti-proliferative effect 
in B16F10 cell lines in vitro.  Present experiments proved that DDSD 
induced intrinsic mitochondrial apoptosis pathway by generating ROS 
and inactivation of PI3K/Akt pathway involving modulating expression 
of Bcl-2 family proteins, leading to apoptosome mediated activation of 
caspase cascade. Based on in vivo antitumor activities against B16F10 
subcutaneously grafted murine melanoma, it appears to be a more 
promising therapeutic compound for melanoma cancer treatment with 
no side effects. The present in vitro and in vivo results demonstrated 
that the DDSD molecule may emerge as efficacious agent for 
therapeutic use 
